Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robert Kill Insider Profile
4 Followers
Robert Kill, President & CEO, Director at Uroplasty, holds 0.00 shares in Uroplasty (Ticker: UPI).
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-24.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Robert Kill does not currently own shares as a corporate insider.
A breakdown of Robert Kill's holdings
Insider Roles
Robert Kill does not currently hold a role as a corporate insider.
Roles that Robert Kill holds in companies
Most Profitable Insider Trade
Stock:
Uroplasty
(UPI)
(UPI)
Rating:Informative Buy
Date:Jan 29, 2015 - Jan 29, 2016
Return:-3.90%
The most profitable trade made by Robert Kill
Robert Kill's Trading History
List of latest transactions for each holding click on a transaction to see Robert Kill's performance on stock
You May Also Like
Robert Kill insider profile FAQ
What is the percentage of profitable transactions made by Robert Kill?
The percentage of profitable transactions made by Robert Kill is 0%.
What is the average return per transaction made by Robert Kill?
The average return per transaction made by Robert Kill is -24.10%.
What stocks does Robert Kill hold?
Robert Kill holds: UPI stocks.
What was Robert Kill’s latest transaction?
Robert Kill latest transaction was an Uninformative Sell of ―.
What was Robert Kill's most profitable transaction?
Robert Kill’s most profitable transaction was an Informative Buy of UPI stock on January 29, 2015. The return on the trade was -3.90%.
What is Robert Kill's role in Uroplasty?
Robert Kill's role in Uroplasty is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.